The ER status (χ2 = 0.53, p = 0.47) and PR status (χ2 = 1.26, p = 0.26) were not significantly different between the HER2-positive and HER2-negative breast cancer brain metastases. This evidence concerns the gene ERBB2 and breast carcinoma.